CN100571722C - Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof - Google Patents
Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof Download PDFInfo
- Publication number
- CN100571722C CN100571722C CNB200610067496XA CN200610067496A CN100571722C CN 100571722 C CN100571722 C CN 100571722C CN B200610067496X A CNB200610067496X A CN B200610067496XA CN 200610067496 A CN200610067496 A CN 200610067496A CN 100571722 C CN100571722 C CN 100571722C
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- vitamin
- kidney
- extractum
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 48
- 230000007812 deficiency Effects 0.000 title claims abstract description 36
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 21
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 59
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 241000208340 Araliaceae Species 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- 241000005787 Cistanche Species 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 16
- 239000002775 capsule Substances 0.000 claims abstract description 16
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 13
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 13
- 239000011720 vitamin B Substances 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000009472 formulation Methods 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 239000007779 soft material Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- -1 reflux Substances 0.000 claims description 3
- 238000007493 shaping process Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 42
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 229940121657 clinical drug Drugs 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 30
- 238000012360 testing method Methods 0.000 description 18
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 15
- 206010022437 insomnia Diseases 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 15
- 208000002173 dizziness Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 230000021595 spermatogenesis Effects 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 239000011800 void material Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 230000001568 sexual effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000008093 supporting effect Effects 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 206010006895 Cachexia Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010024419 Libido decreased Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000026500 emaciation Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 206010029446 nocturia Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000027326 copulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002596 lutein cell Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920000682 polycarbomethylsilane Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | Recovery from illness | Produce effects | Effectively | Invalid | Total effective rate % |
The treatment group | 47 | 38 | 10 | 3 | 97 |
Matched group | 6 | 14 | 9 | 4 | 87.8 |
Project | Treatment precedent number | The routine number in treatment back | Effective percentage % |
Soreness of the waist and knees | 90 | 4 | 95.6 |
Fear of cold | 33 | 2 | 93.9 |
Hyposexuality | 76 | 4 | 94.7 |
Menoxenia | 10 | 1 | 90 |
Lassitude | 66 | 6 | 90.9 |
Insomnia and dreamful sleep | 60 | 2 | 93.3 |
Cardiopalmus | 26 | 1 | 96.2 |
Nocturia | 72 | 4 | 94.4 |
Dizzy | 54 | 3 | 94.4 |
Forgetful | 67 | 3 | 95.5 |
Project | Treatment precedent number | The routine number in treatment back | Effective percentage % |
Soreness of the waist and knees | 29 | 4 | 86.2 |
Fear of cold | 13 | 2 | 84.6 |
Hyposexuality | 14 | 2 | 85.7 |
Menoxenia | 4 | 1 | 75 |
Lassitude | 21 | 3 | 85.7 |
Insomnia and dreamful sleep | 12 | 2 | 83.3 |
Cardiopalmus | 8 | 1 | 87 |
Nocturia | 29 | 4 | 86.2 |
Dizzy | 27 | 3 | 87 |
Forgetful | 24 | 4 | 83.3 |
Group | The example number | The man | The woman | Age |
The treatment group | 361 | 195 | 166 | 35.1±19.1 |
Matched group | 209 | 101 | 108 | 32.9±19.2 |
Group | The example number | Insomnia and dreamful sleep | Headache and dizzy | Cardiopalmus is uncomfortable in chest |
The treatment group | 361 | 97 | 125 | 139 |
Matched group | 209 | 50 | 57 | 102 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610067496XA CN100571722C (en) | 2006-03-29 | 2006-03-29 | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610067496XA CN100571722C (en) | 2006-03-29 | 2006-03-29 | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101045085A CN101045085A (en) | 2007-10-03 |
CN100571722C true CN100571722C (en) | 2009-12-23 |
Family
ID=38770187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610067496XA Expired - Fee Related CN100571722C (en) | 2006-03-29 | 2006-03-29 | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100571722C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109045240B (en) * | 2018-09-06 | 2021-12-31 | 宿州亿帆药业有限公司 | Traditional Chinese medicine composition of Gaocheng preparation, preparation method, detection method and application thereof |
-
2006
- 2006-03-29 CN CNB200610067496XA patent/CN100571722C/en not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
国家药品监督管理局国家中成药标准汇编中成药地方标准上升国家标准部分外科妇科分册. 国家药品监督管理局,134-137. 2002 |
国家药品监督管理局国家中成药标准汇编中成药地方标准上升国家标准部分外科妇科分册. 国家药品监督管理局,134-137. 2002 * |
更辰胶囊治疗肾阳虚证133例临床观察. 朱晓冬等.牡丹江医学院学报,第26卷第3期. 2005 |
更辰胶囊治疗肾阳虚证133例临床观察. 朱晓冬等.牡丹江医学院学报,第26卷第3期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN101045085A (en) | 2007-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
CN102764340A (en) | Traditional Chinese medicine composite capable of improving sleep and preparation method and application thereof | |
CN101623385B (en) | Application of a traditional Chinese medicine composition in the preparation of preparations for treating premature ovarian failure in adult women | |
CN101507776B (en) | Traditional Chinese medicine preparation for treating kidney deficiency, waist and knees soreness and preparation method thereof | |
CN103372197B (en) | Composition for preventing and treating female climacteric syndrome and preparation method thereof | |
CN102698077A (en) | Traditional Chinese medicine composition for treating sub-health | |
CN101045110A (en) | Medicine composition for treating deficiency of the kidney and its preparing method | |
CN103142754A (en) | Traditional Chinese medicine for treating kidney deficiency | |
CN101167846A (en) | Capsule with blood sugar reducing function and preparation method thereof | |
CN102961578A (en) | Traditional Chinese medicine health care product for improving sleep and preparation method thereof | |
CN100571722C (en) | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof | |
CN102125645B (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
CN102125671B (en) | Traditional Chinese medicinal composition for treating gynaecopathia caused by deficiency of the kidney and cold and preparation method thereof | |
CN104324134B (en) | One kind improves microcirculatory Chinese medicine composition and preparation method thereof | |
CN102764338A (en) | Medicine composition for treating renal diseases | |
CN1325099C (en) | Mine-tranquilizing soporific capsule | |
CN102091155B (en) | Traditional Chinese medicine preparation for preventing and treating fatigue due to sub-health | |
CN101249145B (en) | Nerves- soothing Chinese medicinal composition and its applications for preparing climacteric syndrome medicament | |
CN105194355A (en) | Traditional Chinese medicine preparation for treating primary hypertension | |
CN104688999A (en) | Chinese herbal preparation for immunity enhancement | |
CN102727730B (en) | Traditional Chinese medicinal compound preparation for treating male infertility and its preparation method | |
CN109758559A (en) | A kind of Chinese medicine composition and its preparation method and application for treating chronic fatigue syndrome | |
CN102836372A (en) | Composition for improving cerebral circulation and protecting brain cells | |
CN101862376B (en) | Medicament for treating oviduct obstructive infertility and preparation method thereof | |
CN102631496B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine composition for treating deficiency of the kidney and climacteric syndrome and preparation method thereof Effective date of registration: 20120628 Granted publication date: 20091223 Pledgee: Heilongjiang Chen energy Company limited by guarantee Pledgor: Renhetang Pharmaceutical Co., Ltd., Heilongjiang Registration number: 2012990000331 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20130627 Granted publication date: 20091223 Pledgee: Heilongjiang Chen energy Company limited by guarantee Pledgor: Renhetang Pharmaceutical Co., Ltd., Heilongjiang Registration number: 2012990000331 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine composition for treating deficiency of the kidney and climacteric syndrome and preparation method thereof Effective date of registration: 20130627 Granted publication date: 20091223 Pledgee: Heilongjiang Chen energy Company limited by guarantee Pledgor: Renhetang Pharmaceutical Co., Ltd., Heilongjiang Registration number: 2013990000409 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140312 Granted publication date: 20091223 Pledgee: Heilongjiang Chen energy Company limited by guarantee Pledgor: Renhetang Pharmaceutical Co., Ltd., Heilongjiang Registration number: 2013990000409 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091223 Termination date: 20180329 |